Top Health News: Major Investments, Strategic Moves, and Policy Updates

This article summarizes recent significant developments in the health sector, including Johnson & Johnson's investment in a new manufacturing facility, Kailera Therapeutics' entry into the weight-loss market, CVS Health's strategic options, and several other key updates such as Pfizer's stake sale, EU's regulatory decisions, and WHO's new recommendations.

In a major financial commitment, Johnson & Johnson announced plans to invest over $2 billion in a new manufacturing facility in Wilson, North Carolina, focusing on producing biologic medicines aimed at treating cancer, neurological, and immunity-related diseases.

Kailera Therapeutics, a newly launched startup, secured $400 million in early-stage funding to develop anti-obesity therapies. The company is helmed by Ron Renaud, known for his previous role at Cerevel Therapeutics.

CVS Health is reportedly considering a potential break-up to separate its retail and insurance units, amidst investor pressure and lagging performance. The company is exploring various options with financial advisers, though discussions remain confidential.

The European Medicines Agency has retracted the marketing authorization for Abbvie's hepatitis C drug Exviera, following the company's decision to discontinue the product for commercial reasons, effective September 25.

Several health insurers, including Cigna, CVS Health, Humana, Centene, and UnitedHealth, unveiled their Medicare Advantage plans for 2025. This announcement precedes the enrollment window opening on October 15.

Pfizer has reduced its stake in Haleon, the consumer healthcare giant, by selling shares worth $3.26 billion, thereby trimming its ownership to 15%, according to a recent bookrunner statement.

After rare discussions in Washington, Chinese and U.S. health officials have committed to enhanced communication and cooperation on global health issues, including cancer treatment and prevention.

The WHO has endorsed maternal vaccination and administration of antibodies to newborns to combat severe respiratory syncytial virus (RSV) infections, which are a leading cause of infant mortality, particularly in low- and middle-income countries.

A Georgia state judge has blocked a law restricting abortions after six weeks, ruling it violated constitutional rights to privacy and liberty. The order allows abortion services to continue while the state has the option to appeal.

In a move to reduce costs, CVS Health has announced it will lay off approximately 2,900 employees, mainly from corporate roles, which is less than 1% of its workforce. The company's plan will not affect frontline employees in stores and distribution centers.

(With inputs from agencies.)